3 results match your criteria: "Allegheny General Hospital and Allegheny University of the Health Sciences[Affiliation]"
Endocr Pract
February 2005
Department of Ophthalmology and Medicine, Allegheny General Hospital and Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212-4772, USA.
Objective: To review the current role of measurement of serum eye muscle antibodies in thyroid-associated ophthalmopathy (TAO).
Methods: We conducted laboratory studies to determine the prevalences of serum autoantibodies reactive with eye muscle antigens in patients with active and inactive TAO, Graves' hyperthyroidism, and Hashimoto's thyroiditis as well as in normal subjects.
Results: The two antigens most often recognized in immunoblotting with crude human or porcine eye muscle membranes by serum autoantibodies in patients with TAO are eye muscle membrane proteins of 55 and 64 kd.
J Cardiovasc Electrophysiol
August 1998
Cardiology Division, Allegheny General Hospital and Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212-4772, USA.
Thyroid
June 1998
Department of Ophthalmology, Allegheny General Hospital and Allegheny University of the Health Sciences, Pittsburgh, Pennsylvania 15212, USA.
Thyroid-associated ophthalmopathy (TAO) is a progressive orbital disorder associated with Graves' hyperthyroidism and, less often, Hashimoto's thyroiditis in which autoantibodies react with orbital antigens and lead to exophthalmos and eye muscle inflammation. Eye muscle (EM) membrane proteins initially reported as 55 and 64 kd are the best markers of ophthalmopathy. The "64-kd protein" is now shown to be the flavoprotein subunit of mitochondrial succinate dehydrogenase and to have a correct molecular weight of 67 kd.
View Article and Find Full Text PDF